Antimicrobial agents with improved clinical efficacy versus their persistence in the environment: Synthetic 4-quinolone as an example

EcoHealth

Volumn 2, Issue 3, 2005, Pages 171-182

  Jjemba, Patrick K ^a,c   Robertson, Boakai K ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b ALABAMA STATE UNIVERSITY   (United States)

^c University of Cincinnati   (United States)

Author keywords

4 quinolone; Environment; Pharmaceutical agents

Indexed keywords

4 QUINOLONE DERIVATIVE; AMOXICILLIN; ANTIINFECTIVE AGENT; CHLORTETRACYCLINE; CINOXACIN; DANOFLOXACIN; ENOXACIN; ENROFLOXACIN; FLUMEQUINE; GATIFLOXACIN; GEMIFLOXACIN; GREPAFLOXACIN; IVERMECTIN; LOMEFLOXACIN; METRONIDAZOLE; MOXIFLOXACIN; NALIDIXIC ACID; NORDANOFLOXACIN; NORDIFLOXACIN; NORFLOXACIN; OFLOXACIN; OLAQUINDOX; OXALIC ACID; PIPEMIDIC ACID; PIROMIDIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOMYCIN; TIAMULIN; TROVAFLOXACIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; AQUATIC ENVIRONMENT; CLINICAL MEDICINE; DNA STRAND BREAKAGE; DRUG BIOAVAILABILITY; DRUG DEGRADATION; DRUG DESIGN; DRUG EFFICACY; DRUG INDUCED CANCER; DRUG INDUSTRY; DRUG USE; ECOSYSTEM; ENVIRONMENT; ENVIRONMENTAL IMPACT; GENOTOXICITY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; INFECTION; MICROBIAL DEGRADATION; MICROBIAL DIVERSITY; MICROBIAL RESPIRATION; MYASTHENIA GRAVIS; NITRIFICATION; NONHUMAN; PARALYSIS; PLANT GROWTH; PRIORITY JOURNAL; REVIEW; SEWAGE TREATMENT; SOIL; STRUCTURE ACTIVITY RELATION; TENDON DISEASE; VETERINARY MEDICINE;

EID: 24044447619     PISSN: 16129202     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10393-005-6328-4     Document Type: Review

References (77)

1. Alexander M (1994) Biodegradation and Bioremediation, New York: Academic Press
2. Alliance for the Prudent Use of Antibiotics (2004) Shadow epidemic: the growing menace of drug resistance. 2005 Report of the Global Advisory on Antibiotic Resistance Data (GAARD). Available: http://www.tufts.edu/med/apua/ GAARD.pdf [accessed June 30, 2005]
3. Andersson MI, MacGowan AP (2003) Development of the quinolones. Journal of Antimicrobial Chemotherapy 51(Suppl S1):1-11
4. Appelbaum PC, Hunter PA (2000) The fluoroquinolone antibacterial: past, present and future perspectives. International Journal of Antimicrobial Agents 16:5-15
5. Bakal RS, Stoskopf MK (2001) In vitro studies of the fate of sulfadimethoxine and ormetoprim in the aquatic environment. Aquaculture 195:95-102
6. Ball P (2000) Quinolone-induced QT interval prolongation: a not-so unexpected class effect. Journal of Antimicrobial Chemotherapy 45:557-559
7. Boxall ABA, Kolpin DW, Halling-Sørensen B, Tolls J (2003) Are veterinary medicines causing environmental risks?. Environmental Science and Technology 37:286A-294A
8. Brighty KE, Gootz TD (1997) The chemistry and biological profile of trovafioxacin. Journal of Antimicrobial Chemotherapy 39(Suppl B):1-14
9. Burhenne J, Ludwig M, Nikoloudis P, Spiteller M (1997) Photolytic degradation of fluoroquinolone carboxylic acids in aqueous solution. 1. Primary photoproducts and half-lives. Environmental Science and Pollution Research 4:10-15
10. Chee-Sanford JC, Aminov RI, Krapac IJ, Garrigues-Jeanjean N, Mackie RI (2001) Occurrence and diversity of tetracycline resistance genes in lagoons and groundwater underlying two swine production facilities. Applied and Environmental Microbiology 67:1494-1502
11. Chen HJL, Bloch KJ, Maclean JA (2000) Acute eosinophilic hepatitis from trovafloxacin. New England Journal of Medicine 342:359-360
12. Chen Y, Rosazza JPN, Reese CP, Chang H-Y, Nowakowski MA, Kiplinger JP (1997) Microbial models of soil metabolism: biotransformations of danofloxacin. Journal of Industrial Microbiology and Biotechnology 19:378-384
13. Cheng L, Cadario B (2000) Fluoroquinolones and paralysis - what pharmacists should know. British Columbia Drug and Poison Information Center. Available: http://www.fqresearch.org/pdf_files/paralysis.pdf
14. Daughton CG, Ternes TA (1999) Pharmaceutical and personal care products in the environment: agents of subtle changes? Environmental Health Perspectives 107:907-938
15. Davies J, Amábile-Cuevas CF (2003) The rise of antibiotic resistance. In: Multiple Drug Resistant Bacteria, Amábile-Cuevas CF (editor), Wymondham, UK: Horizon Scientific Press, pp 1-7
16. Díaz-Cruz MS, de Lopez Alda MJ, Barcelo D (2003) Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge. Trends in Analytical Chemistry 22:340-351
17. Emmerson AM, Jones AM (2003) The quinolones: decades of development and use. Journal of Antimicrobial Chemotherapy 51(Suppl S1):13-20
18. Epstein BJ, Gums JG, Drlica K (2004) The changing face of antibiotic prescribing: the mutant selection window. Annals of Pharmacotherapy 38:1675-1682
19. Epstein PR (2001) Climate change and emerging infectious diseases. Microbes and Infections 3:747-754
20. European Union (1994) Assessment of Potential Risks for the Environment Posed by Medical Products for Human Use, Excluding Products Containing Live Genetically Modified Organisms. EU Ad Hoc Working Party. III/5504/94. Draft 4, London: European Agency for the Evaluation of Medicinal Products
21. Field JA (2003) Biodegradation of chlorinated compounds by white rot fungi. In: Dehalogenation: Microbial Processes and Environmental Applications, Häggblom MM, Bossert ID. (editors), New York: Kluwer Academic, pp 159-204
22. Food and Drug Administration (1998) Guidance for Industry: Environmental Assessment of Human Drug and Biologics Applications. CMC 6 Revision 1, Rockville, MD: Food and Drug Administration. Available: http://www.fda.gov/cder/ guidance/1730fnl.pdf [accessed 19 October 2004]
23. Gavalchin J, Katz SE (1994) The persistence of fecal-borne antibiotics in soil. Journal of AOAC International 77:481-485
24. Goddard LB, Roth AE, Reisen WK, Scott TW (2002) Vector competence of California mosquitoes for West Nile virus. Emerging Infectious Diseases 8:1385-1391
25. Golet EM, Alder AC, Giger W (2002a) Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt Valley watershed, Switzerland. Environmental Science and Technology 37:3645-3651
26. Golet EM, Alder AC, Hartmann A, Ternes TA, Giger W (2002b) Determination of fluoroquinolone antibacterial agents in sewage sludge and sludge-treated soil using accelerated solvent extraction followed by solid-phase extraction. Analytical Chemistry 74:5455-5462
27. Gootz TD, Barrett JF, Sutcliff JA (1990) Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems. Antimicrobial Agents and Chemotherapy 34:8-12
28. Gunn A, Sadd JW (1994) The effect of ivermectin on the survival, behavior and cocoon production of the earthworm Eisenia foetida. Pedobiologia 38:327-333
29. Haines A, McMicheal AJ, Epstein PR (2000) Global climate changes and health. Canadian Medical Association Journal 163:729-733
30. Halling-Sørensen B (2001) Inhibition of aerobic growth and nitrification of bacteria in sewage sludge by antibacterial agents. Archives of Environmental Contamination and Toxicology 40:451-460
31. Halling-Sørensen B, Holten Lützhøft H-C, Andersen HR, Ingerslev F (2000) Environmental risk assessment of antibiotics: comparison of mecillinam, trimethoprim and ciprofloxacin. Journal of Antimicrobial Chemotherapy 46(Suppl S1):53-58
32. Halling-Sørensen B, Sengeløv G, Ingerslev F, Jensen LB (2003) Reduced antimicrobial potencies of oxytetracycline, tylosin, sulfadiazin, streptomycin, ciprofloxacin and olaquindox due to environmental processes. Archives of Environmental Contamination and Toxicology 44:7-16
33. Halling-Sørensen B, Sengeløv G, Tjornelund J (2002) Toxicity of tetracyclines and tetracycline degradation products to environmentally relevant bacteria, including selected tetracycline-resistant bacteria. Archives of Environmental Contamination and Toxicology 42:263-271
34. Hamscher G, Sczesny S, Hoper H, Nau H (2002) Determination of persistent tetracycline residues in soil fertilized with liquid manure by high-performance liquid chromatography with electrospray ionization tandem mass spectrometry. Analytical Chemistry 74:1509-1518
35. Hawkey P (2003) Mechanisms of quinolone action and microbial response. Journal of Antimicrobial Chemotherapy 51(Suppl S1):29-35
36. Heberer T (2002) Tracking persistent pharmaceutical residues from municipal sewage to drinking water. Journal of Hydrology 266:175-189
37. Herwig RP, Gray JP (1997) Microbial response to antibacterial treatment in marine microcosms. Aquaculture 152:139-154
38. Holten Lützhøft H-C, Halling-Sørensen B, Jørgensen SE (1999) Algal toxicity of antibacterial agents in Danish fish farming. Archives of Environmental Contamination and Toxicology 36:1-6
39. Holten Lützhoft H-C, Vaes WHJ, Freidig AP, Halling-Sørensen B, Hermans JLM (2000) Influence of pH and other modifying factors on the distribution behavior of 4-quinolones to solid phases and humic acids studied by "negligible-depletion" SPME-HPLC. Environmental Science and Technology 34:4989-4994
40. Ingerslev F, Halling-Sørensen B (2000) Biodegradability properties of sulfonamides in activated sludge. Environmental Toxicology and Chemistry 19:2467-2473
41. Jensen J, Krogh PH, Sverdrup LE (2003) Effects of the antimicrobial agents tiamulin, olanquindox and metronidazole and the antihelmintic ivermectin on the soil invertebrate species Folsomia fimetaria (Collembola) and Enchytraeus crypticus (Enchytraeidae). Chemosphere 50:437-443
42. Jjemba PK (2002a) The potential impact of veterinary and human therapeutic agents in manure and biosolids on vegetation: a review. Agriculture Ecosystems and Environment 93:267-278
43. Jjemba PK (2002b) The effect of chloroquine, quinacrine, and metronidazole on both soybean (Glycine max) plants and soil microbiota. Chemosphere 46:1019-1025
44. Jjemba PK (2005) Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. Ecotoxicity and Environmental Safety (in press). Available at DOI: 10.1016/j.ecoenv.2004.11.011
45. Jørgensen SE, Halling-Sørensen B (2000) Drugs in the environment. Chemosphere 40:691-699
46. Knekt P, Aldercreutz H, Rissanen H, Aromaa A, Teppo L, Heliövaara M (2000) Does antibacterial treatment for urinary tract infection contribute to the risk of breast cancer? British Journal of Cancer 82:1107-1110
47. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, et al. (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environmental Science and Technology 36:1202-1211
48. Kovats RS, Haines A (2005) Global climate change and health: recent findings and future steps. Canadian Medical Association Journal 172:501-502
49. Lanzky PF, Halling-Sørensen B (1997) The toxic effects of the antibiotic metronidazole on aquatic organisms. Chemosphere 35:2553-2561
50. Lobitz BL, Beck L, Huq A, Wood B, Fuchs G, Foruque ASG, et al. (2000) Climate and infectious diseases: use of remote sensing for detection of V. chorelae by indirect measurement. Proceedings of the National Academy of Science (USA) 97:1438-1443
51. Louie JP, Bell LM (2002) Appropriate use of antibiotics for common infections in an era of increasing resistance. Emergency Medicine Clinics of North America 20:69-91
52. Lunestad BT, Samuelsen OB, Fjelde S, Ervik A (1995) Photostability of eight antibacterial agents in seawater. Aquaculture 134:217-225
53. 14C)-sarafloxacin hydrochloride in soil. Environmental Toxicology and Chemistry 16:462-471
54. Martens R, Wetzstein H-G, Zadrazil F, Capelari M, Hoffmann P, Schmeer N (1996) Degradation of fluoroquinolone enrofloxacin by wood-rotting fungi. Applied and Environmental Microbiology 62:4206-4209
55. Migliore L, Civitareale C, Cozzolino S, Casoria P, Brambilla G, Gaudio L (1998) Laboratory models to evaluate phytotoxicity of sulphadimethoxine on terrestrial plants. Chemosphere 37:2957-2961
56. Migliore L, Cozzolino S, Fiori M (2000) Phytotoxicity to and uptake of flumequine used in intensive aquaculture on the aquatic weed, Lythrum salicaria L. Chemosphere 40:741-750
57. Nimenya H, Delaunois A, La Duong D, Bloden S, Defour J, Nicks B, et al. (1999) Short-term toxicity of various pharmacological agents on the in vitro nitrification process in a simple closed aquatic system. Alta-Alternatives to Laboratory Animals 27:121-135
58. National Research Council (2000) Biosolids Applied to Land: Advancing Standards and Practices. National Research Council Report to the Committee on Toxicants and Pathogens and Pathogens in Biosolids Applied to Land, Washington, DC: National Academies Press
59. Nowara A, Burhenne J, Spiteller M (1997) Binding of fluoroquinolone carboxylic acid derivatives to clay minerals. Journal of Agricultural and Food Chemistry 45:1459-1463
60. Ohlsen K, Ternes T, Werner G, Wallner U, Loffler D, Ziebuhr W, et al. (2003) Impact of antibiotics on conjugational resistance gene transfer in Staphylococcus aureus in sewage. Environmental Microbiology 5:711-716
61. Petersen A, Andersen JS, Kaewmak T, Somsiri T, Dalsgaard A (2002) Impact of integrated fish farming on antimicrobial resistance in a pond environment. Applied and Environmental Microbiology 68:6036-6042
62. Pursell L, Dineen T, Kerry J, Vaughan S, Smith P (1996) The biological significance of breakpoint concentrations of oxytetracycline in media for the examination of marine sediment microflora. Aquaculture 145:21-30
63. Rapport DJ, Howard JM, Lannigan R, Anjema CM, McCauley W (2001) Strange bedfellows: ecosystem health in the medical curriculum. Ecosystem Health 7:155-162
64. Samuelsen OB, Lunestad BT, Ervik A, Fjeld S (1994) Stability of antibacterial agents in an artificial marine aquaculture sediment studied under laboratory conditions. Aquaculture 126:283-290
65. Schmitt-Kopplin P, Burhenne J, Freitag D, Spiteller M, Kettrup A (1999) Development of capillary electrophoresis methods for the analysis of fluoroquinolones and application to the study of the influence of humic substances on their photodegradation in aqueous phase. Journal of Chromatography A 837:253-265
66. Sithole BB, Guy RD (1987) Models for tetracycline in aquatic environments. 2. Interaction with humic substances. Water Air and Soil Pollution 32:315-321
67. Spaepen KRI, van Leemput LJJ, Wislocki PG, Verschueren C (1997) A uniform procedure to estimate the predicted environmental concentration of the residues of veterinary medicines in soil. Environmental Toxicology and Chemistry 16:1977-1982
68. Stass H, Kubitza D (1999) Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man. Journal of Antimicrobial Chemotherapy 43(Suppl B):83-90
69. Thiele S (2000) Adsorption of the antibiotic pharmaceutical compound sulfapyridine by a long-term differently fertilized loess Chernozem. Journal of Plant Nutrition and Soil Science 163:589-594
70. Threlfall EJ, Ward LR, Skinner JA, Graham A (1997) Increase in multiple antibiotic resistance in nontyphoidal Salmonella from humans in England and Wales: a comparison of data for 1994 and 1996. Microbial Drug Resistance 3:263-266
71. Valicer CM, Heckbert SR, Lampe JW, Potter JD, Robertson CA, Taplin SH (2004) Antibiotic use in relation to the risk of breast cancer. Journal of the American Medical Association 291:827-835
72. van der Linden PD, van Puijenbroek EP, Feenstra J, Veld BA, Sturkenboom MCJM, Herings RMC, et al. (2001) Tendon disorders attributed to fluoroquinolones: a study of 42 spontaneous reports in the period 1988 to 1998. Arthritis Care and Research 45:235-239
73. Volmer DA, Lock SJ (1997) Study of 4-quinolone antibiotics in biological samples by short-column liquid chromatography coupled with electrospray ionization tandem mass spectrometry. Analytical Chemistry 69:4143-4155
74. Westergaard K, Müller AK, Christensen S, Bloem J, Sørensen SJ (2001) Effect of tylosin as a disturbance on the soil microbial community. Soil Biology and Biochemistry 33:2061-2071
75. Wetzstein H-G, Schmeer N, Karl W (1997) Degradation of the fluoroquinolone enrofloxacin by the brown rot fungus Gloeophyllum striatum: identification of metabolites. Applied and Environmental Microbiology 63:4272-4281
76. Wise R (2003) Maximizing efficacy and reducing the emergence of resistance. Journal of Antimicrobial Chemotherapy 51(Suppl S1):37-42
77. Xia K, Bhandari A, Das K, Pillar G (2005) Occurrence and fate of pharmaceuticals and personal care products (PPCPs) in biosolids. Journal of Environmental Quality 34:91-104